Information  X 
Enter a valid email address

Ideagen PLC (IDEA)

  Print   

Thursday 26 August, 2021

Ideagen PLC

PDMR Dealing and Total Voting Rights

RNS Number : 8171J
Ideagen PLC
26 August 2021
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

PDMR Dealing and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that on 25 August 2021 Ian Hepworth, a PDMR and Chief Technology Officer of the company, exercised 167,000 options for the exercise of options over new ordinary shares of 1 pence each ("New Ordinary Shares") in the Company at an exercise price of 112 pence per new Ordinary Share. All 167,000 shares were sold at a price of 290.5 pence.

Application has been made to the London Stock Exchange for the 167,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 1 September 2021.

After Admission, the total number of Ordinary Shares in issue will be 254,655,400 and the total number of voting rights will therefore be 254,655,400. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310

Enquiries:

Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer


Emma Hayes, Chief Financial Officer

 




finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (Nomad)


Alice Lane (ECM)

 


Canaccord Genuity

020 7523 8000

Simon Bridges


Richard Andrews

 

 


FTI Consulting

020 3727 1000

Jamie Ricketts

[email protected]

Dwight Burden


Valerija Cymbal


 



 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, over 6,000 organisations use Ideagen's products including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Hepworth

2. 

Reason for the Notification

a)

Position/status

Chief Technology Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

112 pence

 167,000

d)

Aggregated information:

· Aggregated volume

· Price

Exercise of options over 167,000 ordinary shares of 1p each

e)

Date of the transaction

25 August 2021

f)

Place of the transaction

Outside trading venue

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Hepworth

2. 

Reason for the Notification

a)

Position/status

Chief Technology Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

290.5p

 167,000

d)

Aggregated information:

· Aggregated volume

· Price

Sale of 167,000 ordinary shares at 290.5 pence per share

e)

Date of the transaction

25 August 2021

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEZZGZRZKVGMZZ

a d v e r t i s e m e n t